169 related articles for article (PubMed ID: 7680832)
1. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
Giustina A; Doga M; Bussi AR; Licini M; Schettino M
Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
[TBL] [Abstract][Full Text] [Related]
2. Galanin decreases circulating growth hormone levels in acromegaly.
Giustina A; Bodini C; Doga M; Schettino M; Pizzocolo G; Giustina G
J Clin Endocrinol Metab; 1992 Jun; 74(6):1296-300. PubMed ID: 1375598
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly.
Giustina A; Doga M; Bodini C; Bossoni S; Bresciani E; Bussi AR
Endocr Res; 1993 Dec; 19(4):303-15. PubMed ID: 7508379
[TBL] [Abstract][Full Text] [Related]
4. Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.
Giustina A; Schettino M; Bodini C; Doga M; Licini M; Giustina G
Metabolism; 1992 Dec; 41(12):1291-4. PubMed ID: 1281259
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
7. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
8. Bioactive GH-like immunoglobulins G in active acromegaly: response to long-term treatment with bromocriptine.
Campino C; Szecowka J; Lopez JM; Seron-Ferre M
Clin Endocrinol (Oxf); 1995 Jul; 43(1):111-6. PubMed ID: 7641402
[TBL] [Abstract][Full Text] [Related]
9. CV 205-502 in acromegaly.
Chiodini PG; Attanasio R; Cozzi R; Dallabonzana D; Oppizzi G; Orlandi P; Strada S; Liuzzi A
Acta Endocrinol (Copenh); 1993 May; 128(5):389-93. PubMed ID: 8100375
[TBL] [Abstract][Full Text] [Related]
10. No acute effect of pimozide on the plasma GH levels in acromegaly.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Aug; 103(4):461-8. PubMed ID: 6613492
[TBL] [Abstract][Full Text] [Related]
11. Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women.
Giustina A; Gastaldi C; Bugari G; Chiesa L; Loda G; Tironi C; Negro-Vilar A
Metabolism; 1995 Aug; 44(8):1028-32. PubMed ID: 7543651
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine therapy in acromegaly. A long-term review of 35 cases.
Sachdev Y; Gopal K; Garg VK
Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229
[TBL] [Abstract][Full Text] [Related]
13. Effects of metoclopramide on the growth hormone response to galanin in normal man.
Giustina A; Bussi AR; Doga M; Licini M; Schettino M; Wehrenberg WB
Horm Metab Res; 1993 Sep; 25(9):489-92. PubMed ID: 7693566
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone secretory response to intravenous galanin infusion in acromegalic patients.
Cuerda C; Lucas T; Silvestre RA; Bretón I; García P; Marco J; Barceló B
Exp Clin Endocrinol Diabetes; 1998; 106(1):68-73. PubMed ID: 9516063
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of hydrocortisone on circulating growth hormone levels in patients with acromegaly.
Giustina A; Bussi AR; Licini M; Pizzocolo G; Schettino M; Wehrenberg WB
Horm Res; 1992; 37(6):212-6. PubMed ID: 1363409
[TBL] [Abstract][Full Text] [Related]
17. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine treatment over 12 years in acromegaly: effect on growth hormone and prolactin secretion.
Rau H; Althoff PH; Schmidt K; Usadel KH
Acta Endocrinol (Copenh); 1992 Mar; 126(3):247-52. PubMed ID: 1574954
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly.
Giustina A; Bussi AR; Doga M; Wehrenberg WB
Horm Res; 1994; 41(1):33-7. PubMed ID: 8013941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
